(Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYX ® (cabozantinib) provided significant improvements in progression-free ...
Claude Lemieux's brain is being donated to the Boston University CTE Center to research the long-term effects of repetitive brain injuries, his family said Saturday in a statement released by ...
Some New Jersey voters are starting to notice Tom Kean Jr.’s monthslong absence from Congress due to an undisclosed medical issue. “What's the word?” was the question posed a recent ...
The carcass of a humpback whale has been dragged onto a Danish beach after two weeks of the body languishing in shallow waters. The whale had gained the nicknames “Timmy” ...
Former Arcadia Mayor Eileen Wang has pleaded guilty to being an illegal agent of the Chinese government. The news filled the unassuming suburban city outside of Los Angeles with anger, ...
Artificial intelligence is helping a London-based singer-songwriter continue writing and recording music after Parkinson’s disease largely took away his ability to play guitar. Samuel Smith relied on ...
A family of four from Massachusetts who were killed when a bus crashed into multiple vehicles in Virginia were traveling to a wedding with a carload of homemade desserts for the celebration. The ...
World Health Organization head Tedros Adhanom Ghebreyesus is in eastern Congo’s Bunia, where a rare type of Ebola is spreading faster than the response. WHO director-general's visit on Saturday will ...
A festival honoring Lithuania’s iconic cold beet soup has brought tens of thousands of visitors to its capital city that was fully decked out in pink. The colorful three-day Vilnius ...
A Latvian mountaineering group says three climbers on Alaska’s Mount McKinley who fell near a treacherous pass on North America’s tallest peak have died. A fourth climber has been rescued.
First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with chemotherapy in first-line non-small cell lung cancer across PD-L1 ...